J&J falls despite a beat-and-raise quarter. Why we're raising our price target anyways

Johnson & Johnson beat earnings expectations and raised guidance, though investors sent the stock down regardless. CNBC reports the quarter was imperfect, but fundamentals are solid enough to warrant a raised price target.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton